Place preference conditioning with methylphenidate and nomifensine

M. T. Martin-Iverson, R. Ortmann, H. C. Fibiger

Research output: Contribution to journalArticlepeer-review

59 Citations (Scopus)


The role of central catecholaminergic systems in place preference conditioning produced by methylphenidate and nomifensine was investigated. Several doses of either methylphenidate or nomifensine produced alterations in place preferences, while desipramine (10 mg/kg), a relatively selective noradrenergic uptake inhibitor, was ineffective, Haloperidol (0.15-0.5 mg/kg) did not attenuate place preferences induced with methylphenidate (2.5 and 5.0 mg/kg) or nomifensine (5.0 mg/kg), although conditioning with methylphenidate (5.0 mg/kg) was blocked after injections of a high dose of haloperidol (1.0 mg/kg). Intraventricular injections of 6-hydroxydopamine had no effect on methylphenidate (2.5 mg/kg) induced place preferences. In contrast, pretreatment with haloperidol (0.2 mg/kg) or intraventricular injections of 6-hydroxydopamine attenuated locomotor activity induced by methylphenidate (5.0 mg/kg). These results suggest that methylphenidate and nomifensine produce place preferences via mechanisms that are either qualitatively or quantitatively distinct from their catecholamine-dependent stimulant actions.

Original languageEnglish
Pages (from-to)59-67
Number of pages9
JournalBrain Research
Issue number1
Publication statusPublished - 15 Apr 1985
Externally publishedYes


Dive into the research topics of 'Place preference conditioning with methylphenidate and nomifensine'. Together they form a unique fingerprint.

Cite this